Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by Frogger2on Mar 17, 2015 3:39pm
266 Views
Post# 23530952

RE:Partnership negociations

RE:Partnership negociationsTson, I pasted a slide describing the process TST is following below. I think Your comments are valid but I think that the plan is not to take on a partner until the BLA is submitted, if TST chooses that path. I'm sure there is a long due diligence process for TST and interested parties and believe they will take their time and make the right choice by viewing as many as possible. They are also well aware of their financial position and I trust will take the most logical steps in managing through this. I have faith that this group has a plan in place and has considered all risks and scenarios that may be presented as they move forward. I'm sitting back and watching this unfold, I hope we have a positive decision in the end. 2015 – Focus on Value Growth… •  High quality BLA submission •  Complete 3rd party market assessment •  Confirmed premium pricing, market access and market opportunity •  3rd party assessment critical for partnering discussions •  Run structured partnering process to identify highest value strategic option for MCNA •  Traditional licensing transaction – US and/or global/regional •  Joint Venture/Profit Share •  Company Sale •  Retain product ownership post-approval and launch product   Increase shareholder value (share price!)
<< Previous
Bullboard Posts
Next >>